179 related articles for article (PubMed ID: 8551788)
1. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass.
Morioka K; Muraoka R; Chiba Y; Ihaya A; Kimura T; Noguti H; Uesaka T
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):45-54. PubMed ID: 8551788
[TBL] [Abstract][Full Text] [Related]
2. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass.
Chiba Y; Morioka K; Muraoka R; Ihaya A; Kimura T; Uesaka T; Tsuda T; Matsuyama K
Ann Thorac Surg; 1998 Jan; 65(1):107-13; discussion 113-4. PubMed ID: 9456104
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery.
Gu YJ; de Vries AJ; Boonstra PW; van Oeveren W
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):494-500. PubMed ID: 8751518
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte and platelet depletion with a blood cell separator.
Taggart DP
J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1406. PubMed ID: 8911350
[No Abstract] [Full Text] [Related]
5. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study.
Mihaljevic T; Tönz M; von Segesser LK; Pasic M; Grob P; Fehr J; Seifert B; Turina M
J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1138-45. PubMed ID: 7776678
[TBL] [Abstract][Full Text] [Related]
6. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
7. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
9. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
[TBL] [Abstract][Full Text] [Related]
10. Effects of pulsatile and nonpulsatile perfusion mode during extracorporeal circulation--a comparative clinical study.
Dapper F; Neppl H; Wozniak G; Strube I; Zickmann B; Hehrlein FW; Neuhof H
Thorac Cardiovasc Surg; 1992 Dec; 40(6):345-51. PubMed ID: 1290181
[TBL] [Abstract][Full Text] [Related]
11. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.
Teoh KH; Christakis GT; Weisel RD; Wong PY; Mee AV; Ivanov J; Madonik MM; Levitt DS; Reilly PA; Rosenfeld JM
J Thorac Cardiovasc Surg; 1988 Aug; 96(2):332-41. PubMed ID: 3398555
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of prostacyclin and thromboxane in children before, during, and after cardiopulmonary bypass.
Fleming WH; Sarafian LB; Leuschen MP; Newland MC; Kennedy EM; Kugler JD; Chapin JW; Hurlbert BJ; Bolam DL; Nelson RM
J Thorac Cardiovasc Surg; 1986 Jul; 92(1):73-8. PubMed ID: 3755198
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ulinastatin on plasma polymorphonuclear leukocyte elastase activity and respiratory function in patients undergoing cardiopulmonary bypass].
Mishima A; Takeuti Y; Usami S; Kotani H; Suzuki Y; Yura J
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):607-12. PubMed ID: 2373894
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
15. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor.
Butler J; Parker D; Pillai R; Westaby S; Shale DJ; Rocker GM
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):25-30. PubMed ID: 8419705
[TBL] [Abstract][Full Text] [Related]
16. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.
van Oeveren W; Jansen NJ; Bidstrup BP; Royston D; Westaby S; Neuhof H; Wildevuur CR
Ann Thorac Surg; 1987 Dec; 44(6):640-5. PubMed ID: 2446574
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
[TBL] [Abstract][Full Text] [Related]
18. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
[TBL] [Abstract][Full Text] [Related]
19. [Effects of anisodamine (654-2) on plasma levels of thromboxane B2, 6-keto-PGF1 alpha and platelet cAMP following cardiopulmonary bypass].
Huang Y; Liu YT
Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):669-71, 46. PubMed ID: 2854751
[No Abstract] [Full Text] [Related]
20. Systemic leukocyte filtration during cardiopulmonary bypass.
Fabbri A; Manfredi J; Piccin C; Soffiati G; Carta MR; Gasparotto E; Nardon G
Perfusion; 2001 Mar; 16 Suppl():11-8. PubMed ID: 11334202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
